Zecotek Developing 3D Printer with LT-Pyrkal

Zecotek to Develop 3D Printer

Singapore, February 27, 2014 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its wholly owned subsidiary Zecotek Display Systems Pte. Ltd. is designing a unique 3D printer which will offer technical and commercial competitive advantages to existing 3D printers. Zecotek is working with LT-Pyrkal of Yerevan, Armenia, a long time contract partner which developed a number of key elements for Zecotek`s own patented 3D display technology. This is Zecotek`s second product offering to the 3D market following the recently announced 3D printing platform which offers significant design, cost, and time advantages when Zecotek’s glasses free, auto-stereoscopic, multi-view, HD 3D display.

“By combining our vast experience in laser technology and high precision electro-mechanical devices Zecotek and LT-Pyrkal are exploring novel designs for a compact and high speed 3D printer,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “Our technical expertise has allowed our partnership to explore new and more efficient methods of printing 3 dimensional objects with a large spectrum of materials. We are testing components of a compact, high speed 3D printer to be used in rapid prototyping and rapid manufacturing, as well as the associated software interface and look forward to working with LT-Pyrkal to move this project forward.”

3D printing is the process of making three dimensional solid objects from a digital model by laying down successive layers of material in different shapes. Companies are using 3D printing to evaluate more product models in less time to improve design throughout the product development process. As the design of a product advances, technical issues are tested at various points to achieve improved performance, lower manufacturing costs, while delivering higher quality and more successful product launches. In rapid prototyping, 3D printing is enables faster more efficient production that supports marketing and sales. Rapid manufacturing enables higher productivity, economical customization, improved quality and greater efficiency in a growing number of industries.

Total annual sales and service of 3D printers has reached $2 billion. Leading industry analysts predict continued significant growth with annual sales of 3D printing reaching $4 billion by 2015, and over $10 billion by 2021. The rapid growth in the market is due to the improving performance of additive equipment and the expanding range of materials being used. Although 3D printing has now become cheaper and more customizable than regular manufacturing methods, there are a number of opportunities for improvement. Zecotek and LT-Pyrkal new 3D printer will be used for both prototyping and distributed manufacturing with applications in many industries including dental, medical, biotech, architecture, industrial design, aerospace, military, civil engineering, and geographic information systems.

-30-

About LT-Pyrkal
LT-PYRKAL is a Greek-Armenian research, development and production company, specializing in crystal growth, laser accessories and components, lasers and systems. LT-PYRKAL was established in 1999 and todays employs over 250 highly qualified specialists and occupies over 30.000 square meters of industrial facilities for for synthetic crystal growth, opto-mechanics and laser electronics manufacturing, and laser and EO Systems development. For more information please visit: http://www.lt-pyrkal.com/en/.

About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Laser Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners such as Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), and National NanoFab Center (South Korea). For more information visit Zecotek Photonics, follow @zecotek on Twitter and “like” us in Facebook.

This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.

For Additional Information Please Contact:

The TSX Venture 50® are the top 10 companies listed on the TSX Venture Exchange, in each of five major industry sectors – mining, oil & gas, technology & life sciences, diversified industries and clean technology – based on a ranking formula with equal weighting given to return on investment, market cap growth, trading volume and analyst coverage. All data was as of December 31, 2013.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.